Hair loss more likely with Ozempic, other semaglutide drugs, study suggests [Video]

Semaglutide medications like Ozempic and Wegovy have exploded in popularity in recent years due to their effectiveness in diabetes control and weight loss. 

Research has revealed additional benefits beyond those primary uses — but some negative side effects have also emerged.

While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked GLP-1 (glucagon-like peptide-1) agonists — the class of drugs that includes semaglutides — to an increased risk of hair loss.

MEN GOING BALD TURN TO ‘NEW BOTOX’ FOR HAIR LOSS TREATMENT

The researchers analyzed data from 16 million patients from a health claims database, narrowing it down to 1,926 semaglutide users and 1,348 users of bupropion-naltrexone, another type of weight-loss medication.

After adjusting for other factors, they found that the semaglutide users were overall 50% more likely to experience hair loss compared to the other group.

Women were more likely to have this outcome, with twice …